If you’re considering treatment with Vumerity, you may wonder how it compares with alternate treatments such as ocrelizumab (Ocrevus) and teriflunomide (Aubagio). Vumerity, Aubagio, and Ocrevus ...

The MUSETTE trial found no additional benefit in higher doses of ocrelizumab for RMS compared to the standard 600 mg dose. The 600 mg dose of ocrelizumab remains optimal for slowing disability ...

近日，浦东跨国企业罗氏制药旗下创新药罗可适®（Ocrevus®，通用名：奥瑞利珠单抗注射液/ocrelizumab injection）获得中国国家 ...

(Journal of Neurology, Neurosurgery, and Psychiatry) A higher dose of ocrelizumab (Ocrevus) did not meet the primary endpoint in the MUSETTE trial of multiple sclerosis (MS), Roche said.

3月31日，罗氏（Roche）刚刚宣布奥瑞利珠单抗注射液（ocrelizumab injection）正式获得中国国家药品监督管理局（NMPA）批准，每六个月静脉输注一次给药，用于治疗成人复发型多发性硬化症（RMS，包括临床孤立综合征、复发缓解型多发性硬化和活动性继发进展型多发 ...

A phase 3 study evaluating a higher dose of ocrelizumab in adults with relapsing multiple sclerosis (MS) failed to meet its primary endpoint. The study aimed to determine whether treatment with ...

Process Governor is a utility that automates the management of Windows processes and services by adjusting their priorities, I/O priorities, and core affinity according to user-defined rules ...

Introduction: Pancreatic cancer shows very poor prognosis and high resistance to conventional standard chemotherapy and immunotherapy; therefore, the development of new breakthrough therapies is ...

此次奥瑞利珠单抗在中国获批主要依据OPERA I、OPERA II和ORATORIO等多个全球III期临床研究的积极结果。 2025年3月31日，罗氏制药今日宣布，其旗下创新药 ...

The 2025 NFL Draft is less than a month away, and every year there are surprising trades on opening night that force teams to change course with their draft boards. Could the Dallas Cowboys be one ...